Correlation between initial tumour volume and treatment duration on Dabrafenib: observation study of subjects with BRAF mutant melanoma on the BRF112680 trial. [electronic resource]
Producer: 20210112Description: 342 p. digitalISSN:- 1471-2407
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- therapeutic use
- Duration of Therapy
- Female
- Follow-Up Studies
- Humans
- Imidazoles -- therapeutic use
- Male
- Melanoma -- drug therapy
- Middle Aged
- Mutation
- Oximes -- therapeutic use
- Prognosis
- Proto-Oncogene Proteins B-raf -- genetics
- Retrospective Studies
- Survival Rate
- Tumor Burden -- drug effects
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Observational Study
There are no comments on this title.
Log in to your account to post a comment.